NIH Awards Hesperos Research Grant to Develop Animal-Free Botox Testing Platform

Hesperos was awarded a $2 million research grant by the National Center for Advancing Translational Sciences in collaboration with the US FDA. The goal of the effort is to develop an advanced testing platform capable of assessing the potency of the Botulinum Toxin without the need for animal testing.
[Hesperos, Inc.]
Press Release